FirstWord Publishing, June 2010, Pages: 46
.
In Branded Generics--A Gateway to EmergingMarkets , the authors delve into the potential of branded generics, and the progress key companies are already experiencing. The report, which explores the strategies
GBI Research, May 2011, Pages: 69
Study 41
6.5.2 Example of Paragraph IV Challenge That Did Not Work Out for a Generic 42
6.6 Expansion to Pharmerging Markets – Opportunities in BRIC Countries 43
6.6.1 EmergingMarkets Pose an Attractive
Decision Resources, Inc., Nov 2011
business, many Big Pharma companies are implementing strategies to take advantage of generics opportunities in both established and emerging pharmaceutical markets.
These endeavors offer the potential
Cutting Edge Information, June 2010, Pages: 246
changes in US biosimilars legislation
- Biologics’ counter-genericsstrategies
Company and brand counter-generics profiles:
- Basic company information (size, markets)
- Functions leading
Business Insights, Aug 2010, Pages: 160
their positions at the head of the generic company sales rankings; national and regional businesses have emerged as major forces in emerginggenericmarkets; while new players – including multinationals – have
Frost & Sullivan, Dec 2008, Pages: 75
participants. Revenue forecasts has been discussed. It also provides strategic recommendations.
This Frost & Sullivan research service titled EmergingGeneric Pharmaceuticals Markets in Europe provides
FirstWord Publishing, Sep 2010, Pages: 260
Generics—A Gateway to EmergingMarkets
Branded generics—hybrids that allow companies to use existing marketing and distribution to offer premium-priced, brand-name generics to consumers—are taking hold in E
Datamonitor, April 2011, Pages: 70
generics players and the strategies they have implemented in both the developed and emergingmarkets.
- Insight into future opportunities for generics players
Highlights
- In response to rising healthcare
CBR Pharma Insights, April 2010, Pages: 54
strategies. These strategies include: sales force growth, tiered pricing, generics, acquisitions/partnerships and an urban vs. rural focus.
The EmergingMarketsStrategies report assesses why companies
Frost & Sullivan, Sep 2010, Pages: 152
are being unleashed to cash in on the growth opportunities. Outsourcing of manufacturing and internal functions is the current trend. In most emergingmarkets in Southeast Asia, there are changes
CBR Pharma Insights, March 2011, Pages: 52
- Develop effective business strategies in areas such as patient adherence, generic competition, health care changes, and emergingmarkets
- Identify & exploit where and how you can support your brand
Datamonitor, Nov 2011, Pages: 36
- Compares the Canadian generics market in terms of value and volume to other leading developed and emergingmarkets.
- Insight into the key drivers and resistors to generics uptake in Canada, and identifies
FirstWord Publishing, Oct 2010, Pages: 52
and policy sketches of the five dominant countries in the region, the report goes beyond a battlefield to offer marketing and development strategies by generics and Big Pharma, as well as an “Outlook” section
Business Insights, Dec 2010, Pages: 102
The report traces how regulatory policy, in particular relating to intellectual property, has shaped the emergingmarkets. In doing so, it explores differences in the treatment of generics
Pharma-Reports, Jan 2012, Pages: 80
by Generic Producers
- Impact of Price Cuts by Governments
- Preference of Brand Loyalty
- U.S. Healthcare Reforms Tough on Generic Companies
- Emergence of Pay-for-Delay Model
Pharma Trends in BRIC
UBM Canon, Dec 2010, Pages: 403
and Prilosec, were heavily marketed prior to going generic and then were successfully introduced to the over-the-counter market. In another effort to recover lost revenue, a company may license authorized
Aruvian's R'search, Jan 2011, Pages: 80
of the previous marketing efforts of the brand-name drug company, including media advertising, presentations by drug representatives, and distribution of free samples. Many of the drugs introduced by generic
VOI Consulting, Inc., March 2009, Pages: 500
property status and expirations dates for all branded drug products
- Emerging competition in India,China and Eastern Europe
- Recent Mergers and Aquistions
- Impact of Bio generics
Product & Market Section
